Skip to main content
Caplight Logo









Tensegrity Pharma, Inc.

Tensegrity Pharma, Inc.

Private
TokyoHealthcare & Life Scienceshttps://tensegritypharma.com/index.html

Last Round

Seed

Nov 13, 2024

Total Funding Raised

$4.15M

Company Overview

Tensegrity Pharma, Inc. is a biotechnology company that develops therapeutic candidates by reclaiming and advancing strategically discontinued drug projects for clinical validation.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biotechnologydrug developmentclinical trialsmonoclonal antibodyasset out-licensingbiotech startupcancer cachexiadrug discoverytherapeutic candidatebiopharmaclinical validationdrug repurposingM&Apharma pipelineshelved assets

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Tensegrity Pharma, Inc. Comparables

Compare Tensegrity Pharma, Inc. with similar companies based on industry and business-model similarity.

Tensegrity Pharma, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Actimed Therapeutics
82%
Artelo Biosciences, Inc.
71%
Pfizer
66%

Tensegrity Pharma, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedNov 13, 2024

Key People

Founding team and executive leadership

中原崇人

Founder and CEO

Founding Team

Tensegrity Pharma, Inc. Investors

Notable investors and investment history

Tensegrity Pharma, Inc. investors
InvestorRounds
Newton BiocapitalSeed
Mitsubishi UFJ CapitalSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 24, 2025

    Grew 100% QoQ, from 4 to 8 employees.

  • Oct 15, 2025

    Grew 75% QoQ, from 4 to 7 employees.

Tensegrity Pharma, Inc. Filings

Explore SEC and related filing metadata, where available.

Tensegrity Pharma, Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Tensegrity Pharma, Inc.'s valuation, stock price, and market status.

Is Tensegrity Pharma, Inc. a public or private company?

Tensegrity Pharma, Inc. is a private company.

What is the current stock price of Tensegrity Pharma, Inc.?

Tensegrity Pharma, Inc. is a private company with no public stock price. Caplight tracks Tensegrity Pharma, Inc.'s secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is Tensegrity Pharma, Inc. worth (valuation)?

Valuation information for Tensegrity Pharma, Inc. is not publicly available.

Can I buy Tensegrity Pharma, Inc. stock?

Tensegrity Pharma, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Tensegrity Pharma, Inc.'s last funding round?

Tensegrity Pharma, Inc.'s most recent funding round was Seed on November 13, 2024.

Who are the main investors in Tensegrity Pharma, Inc.?

Key investors in Tensegrity Pharma, Inc. include Newton Biocapital.

Will Tensegrity Pharma, Inc. IPO soon?

No public IPO plans have been announced for Tensegrity Pharma, Inc..

How can I track Tensegrity Pharma, Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Tensegrity Pharma, Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersTokyo
Employee Range6
Year Founded2023
Last FundingNov 13, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?